Caris Life Sciences (NASDAQ:CAI) reported a record fourth quarter in its first full year as a public company, driven by ...

Caris Life Sciences Inc (CAI) reports a 125% revenue increase, positive net income, and ambitious 2026 growth targets, driven by molecular profiling success and upcoming innovations.

In this webinar, Jorge López, MSc, Flow Cytometry and Hematology Specialist, will discuss the implementation of PIDOT within a Next Generation Flow™ cytometry framework as a sta ...

We are focused on building on this momentum, advancing our pipeline, and are particularly excited about the planned launch of ...

Reliable flow data forms the foundation of every meaningful water resource study”— Joel Chaky BATON ROUGE, LA, UNITED ...

Joining the call from Caris today are David Dean Halbert, our Founder, Chairman and CEO; David Spetzler, our President; Brian Brille, our Vice Chairman and EVP; Bobby Hill, our Chief Commercial ...

“People go to the grocery store to buy goods and get discounts and deals – and not to be tracked, profiled, or have their ...

Highl ights Fourth quarter 2025 revenue of $209.8 million was consistent with fourth quarter 2024 revenue, but grew 4% year-over-year when ...

The funding debate in Congress is over immigration-enforcement practices, but the Administration is still spending ...

Caris Life Sciences Inc. CAI shares are up during Friday’s premarket session following better-than-expected fourth-quarter earnings and a significant interim readout from the company’s Achieve 1 study ...

NINGBO, ZHEJIANG, CHINA, January 22, 2026 /EINPresswire.com/ -- How to Choose the Right Milling Cutter (A Practical ...

FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming ...